Patents Assigned to Atreca, Inc.
-
Publication number: 20240327505Abstract: Described herein are antibodies or variants thereof that specifically bind to coronavirus antigens, such as SARS-CoV-2 antigens. The antibodies can be neutralizing antibodies. Also provided are methods of using the antibodies, including methods of treating a subject infected with SARS-CoV-2, and methods of diagnosing a subject infected with SARS-CoV-2.Type: ApplicationFiled: October 20, 2022Publication date: October 3, 2024Applicants: University of Vermont and State Agricultural College, Atreca, Inc.Inventors: Jason Botten, Katherine L. Williams, Ngan Nguyen Atkins, Annalis Whitaker
-
Publication number: 20240301038Abstract: Described herein are antibodies or variants thereof that specifically bind to coronavirus antigens, such as SARS-CoV-2 antigens. The antibodies can be neutralizing antibodies. Also provided are methods of using the antibodies, including methods of treating a subject infected with SARS-CoV-2, and methods of diagnosing a subject infected with SARS-CoV-2.Type: ApplicationFiled: March 24, 2022Publication date: September 12, 2024Applicants: Atreca, Inc., University of Vermont and State Agricultural CollegeInventors: Katherine L. Williams, Daniel Eric Emerling, Shaun M. Lippow, Ngan Nguyen Atkins, Jason Botten, Annalis Whitaker
-
Publication number: 20230167169Abstract: The present disclosure provides anti-circumsporozoite (CSP) antibodies, compositions comprising such antibodies. Also disclosed are methods of producing the disclosed antibodies and methods of treating or preventing malaria using the same.Type: ApplicationFiled: January 26, 2023Publication date: June 1, 2023Applicant: Atreca, Inc.Inventors: Daniel Eric Emerling, Randal R. Ketchem, Shaun M. Lippow, Wayne Volkmuth, Katherine L. Williams
-
Patent number: 11655290Abstract: The present disclosure provides anti-circumsporozoite (CSP) antibodies, compositions comprising such antibodies. Also disclosed are methods of producing the disclosed antibodies and methods of treating or preventing malaria using the same.Type: GrantFiled: June 16, 2022Date of Patent: May 23, 2023Assignee: Atreca, Inc.Inventors: Daniel Eric Emerling, Randal R. Ketchem, Shaun M. Lippow, Wayne Volkmuth, Katherine L. Williams
-
Publication number: 20230002483Abstract: The present disclosure provides anti-circumsporozoite (CSP) antibodies, compositions comprising such antibodies. Also disclosed are methods of producing the disclosed antibodies and methods of treating or preventing malaria using the same.Type: ApplicationFiled: June 16, 2022Publication date: January 5, 2023Applicant: Atreca, Inc.Inventors: Daniel Eric Emerling, Randal R. Ketchem, Shaun M. Lippow, Wayne Volkmuth, Katherine L. Williams
-
Publication number: 20220389471Abstract: Provided herein are methods and compositions for analyzing nucleic acids associated with single cells using nucleic acid barcodes. According to some embodiments, a method for producing one or more polynucleotides of interest comprises: obtaining a plurality of RNAs associated with one or more samples, wherein the samples are obtained from one or more subjects, each RNA is associated with a single sample, and the RNAs associated with each sample are present in a separate reaction volume; adding an adapter molecule to the RNAs associated with each sample, wherein the adapter molecule is generated using an enzymatic reaction and comprises a universal priming sequence, a barcode sequence, and a binding site; and incorporating the barcode sequence into one or more polynucleotides associated with each sample, thereby producing the one or more polynucleotides of interest.Type: ApplicationFiled: June 17, 2022Publication date: December 8, 2022Applicants: Atreca, Inc., Atreca, Inc.Inventors: Yann Chong TAN, Gary WITHEY
-
Patent number: 11472885Abstract: Provided herein are antibodies that bind to tumor tissue through a binding interaction with an extracellular RNA-protein complex. Such antibodies are used in methods of inducing an immune response and methods of inhibiting tumor cell growth. Additionally provided are methods of producing such antibodies.Type: GrantFiled: February 14, 2020Date of Patent: October 18, 2022Assignee: Atreca, Inc.Inventors: Jeff DeFalco, Daniel Eric Emerling, Jessica Finn, Norman Michael Greenberg, Vera Huang, Shaun M. Lippow, Fengling Liu, Amy Manning-Bog, William H. Robinson, Alexander Scholz, Tito Serafini, Yann Chong Tan, Nikhil Vad, Wayne Volkmuth
-
Patent number: 11098304Abstract: Provided herein are methods of identifying the origin of a nucleic acid sample. The methods include forming a reaction mixture comprising a nucleic acid sample comprising nucleic acid molecules from a single cell and a set of barcodes, incorporating the set of barcodes into the nucleic acid molecules of the sample, and identifying the set of barcodes incorporated into the nucleic acid molecules of the single cell thereby identifying the origin of the nucleic acid sample.Type: GrantFiled: November 4, 2016Date of Patent: August 24, 2021Assignee: ATRECA, INC.Inventor: Gary Withey
-
Patent number: 11066464Abstract: Antibodies that bind to the circumsporozoite protein (CSP) of Plasmodium falciparum. Use of such antibodies as anti-malarial agents, to confer protection against infection by malarial parasites such as P. falciparum by insect vector transmission. Diagnosis of malaria using anti-CSP antibodies. Methods of determining efficacy of candidate vaccine compositions in development and testing of anti-malarial vaccines.Type: GrantFiled: May 11, 2018Date of Patent: July 20, 2021Assignees: KYMAB LIMITED, ATRECA, INC.Inventors: Qi Liang, Sean Matthew Carroll, Daniel Eric Emerling, Allan Bradley, Paul Kellam, {hacek over (S)}pela Binter, Simon James Watson
-
Patent number: 10620219Abstract: Disclosed herein are methods and compositions for using nanoexpression to interrogate antigen specificity within antibody repertoires. Also disclosed herein is an antibody display system composition comprising one or more recombinant nucleic acid sequences comprising a first nucleic acid sequence encoding a heavy chain variable region sequence or fragment thereof operatively linked to a first identification region sequence and a second nucleic acid sequence encoding a light chain variable region sequence or fragment thereof operatively linked to a second identification region sequence.Type: GrantFiled: December 13, 2017Date of Patent: April 14, 2020Assignee: ATRECA, INC.Inventors: Jeff DeFalco, Daniel Emerling, Shaun Lippow, Sean Carroll, Wayne Volkmuth, Norm Greenberg, Tito Serafini
-
Patent number: 10316345Abstract: Provided herein are methods and compositions for analyzing nucleic acids associated with single cells using nucleic acid barcodes. According to some embodiments, a method for producing one or more polynucleotides of interest comprises: obtaining a plurality of RNAs associated with one or more samples, wherein the samples are obtained from one or more subjects, each RNA is associated with a single sample, and the RNAs associated with each sample are present in a separate reaction volume; adding an adapter molecule to the RNAs associated with each sample, wherein the adapter molecule is generated using an enzymatic reaction and comprises a universal priming sequence, a barcode sequence, and a binding site; and incorporating the barcode sequence into one or more polynucleotides associated with each sample, thereby producing the one or more polynucleotides of interest.Type: GrantFiled: February 8, 2017Date of Patent: June 11, 2019Assignee: ATRECA, INC.Inventors: Yann Chong Tan, Gary Withey
-
Publication number: 20180362628Abstract: Antibodies that bind to the circumsporozoite protein (CSP) of Plasmodium falciparum. Use of such antibodies as anti-malarial agents, to confer protection against infection by malarial parasites such as P. falciparum by insect vector transmission. Diagnosis of malaria using anti-CSP antibodies. Methods of determining efficacy of candidate vaccine compositions in development and testing of anti-malarial vaccines.Type: ApplicationFiled: May 11, 2018Publication date: December 20, 2018Applicants: KYMAB LIMITED, ATRECA, INC.Inventors: Qi Liang, Sean Matthew Carroll, Daniel Eric Emerling, Allan Bradley, Paul Kellam, Spela Binter, Simon James Watson
-
Patent number: 9834766Abstract: The present disclosure provides methods for optimizing barcode design for multiplex DNA sequencing. Also disclosed are DNA barcodes optimized for use with particular sequencing technologies.Type: GrantFiled: September 4, 2012Date of Patent: December 5, 2017Assignee: Atreca, Inc.Inventors: Wayne Volkmuth, Yann Chong Tan
-
Patent number: 9580736Abstract: Provided herein are methods and compositions for analyzing nucleic acids associated with single cells using nucleic acid barcodes. According to some embodiments, a method for producing one or more polynucleotides of interest comprises: obtaining a plurality of RNAs associated with one or more samples, wherein the samples are obtained from one or more subjects, each RNA is associated with a single sample, and the RNAs associated with each sample are present in a separate reaction volume; adding an adapter molecule to the RNAs associated with each sample, wherein the adapter molecule is generated using an enzymatic reaction and comprises a universal priming sequence, a barcode sequence, and a binding site; and incorporating the barcode sequence into one or more polynucleotides associated with each sample, thereby producing the one or more polynucleotides of interest.Type: GrantFiled: December 30, 2014Date of Patent: February 28, 2017Assignee: Atreca, Inc.Inventors: Yann Chong Tan, Gary Withey
-
Publication number: 20150080266Abstract: The present disclosure provides methods for optimizing barcode design for multiplex DNA sequencing. Also disclosed are DNA barcodes optimized for use with particular sequencing technologies.Type: ApplicationFiled: September 4, 2012Publication date: March 19, 2015Applicant: Atreca, Inc.Inventors: Wayne Volkmuth, Yann Chong Tan